Champions Oncology Inc (CSBR)
4.85
-0.07
(-1.42%)
USD |
NASDAQ |
Apr 30, 16:00
Champions Oncology 1 Year Total Returns (Daily): -1.42% for April 30, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 30, 2024 | -1.42% |
| April 29, 2024 | 0.00% |
| April 26, 2024 | 0.52% |
| April 25, 2024 | 1.20% |
| April 24, 2024 | -0.59% |
| April 23, 2024 | -2.12% |
| April 22, 2024 | -2.32% |
| April 19, 2024 | -3.80% |
| April 18, 2024 | -8.41% |
| April 17, 2024 | -3.45% |
| April 16, 2024 | 8.85% |
| April 15, 2024 | 4.17% |
| April 12, 2024 | 7.53% |
| April 11, 2024 | 4.71% |
| April 10, 2024 | 6.47% |
| April 09, 2024 | 10.18% |
| April 08, 2024 | 10.18% |
| April 05, 2024 | 10.45% |
| April 04, 2024 | 18.90% |
| April 03, 2024 | 21.89% |
| April 02, 2024 | 26.12% |
| April 01, 2024 | 22.14% |
| March 28, 2024 | 20.10% |
| March 27, 2024 | 19.04% |
| March 26, 2024 | 17.57% |
| Date | Value |
|---|---|
| March 25, 2024 | 21.78% |
| March 22, 2024 | 30.12% |
| March 21, 2024 | 26.67% |
| March 20, 2024 | 37.16% |
| March 19, 2024 | 27.50% |
| March 18, 2024 | 30.50% |
| March 15, 2024 | 33.41% |
| March 14, 2024 | 25.52% |
| March 13, 2024 | 23.87% |
| March 12, 2024 | 26.28% |
| March 11, 2024 | 25.17% |
| March 08, 2024 | 24.09% |
| March 07, 2024 | 22.49% |
| March 06, 2024 | 22.90% |
| March 05, 2024 | 24.18% |
| March 04, 2024 | 23.96% |
| March 01, 2024 | 20.52% |
| February 29, 2024 | 26.88% |
| February 28, 2024 | 26.88% |
| February 27, 2024 | 20.56% |
| February 26, 2024 | 29.35% |
| February 23, 2024 | 24.91% |
| February 22, 2024 | 28.41% |
| February 21, 2024 | 32.41% |
| February 20, 2024 | 42.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-67.66%
Minimum
Sep 30 2019
191.4%
Maximum
Mar 18 2021
-0.83%
Average
-15.39%
Median
1 Year Total Returns (Daily) Benchmarks
| AIM ImmunoTech Inc | -14.90% |
| Perspective Therapeutics Inc | 169.9% |
| Protalix BioTherapeutics Inc | -58.99% |
| Electromed Inc | 58.81% |
| Armata Pharmaceuticals Inc | 57.41% |